Endo, AbbVie Back Philly Testosterone Case Consolidation
By Matt Fair ( March 17, 2016, 5:44 PM EDT) -- A group of drugmakers including AbbVie Inc. and an Endo Pharmaceuticals Inc. unit have thrown their support behind a bid to create a new mass tort program in Pennsylvania state court to coordinate a cluster of cases over heart attacks and strokes allegedly caused by testosterone-containing products....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.